Kush M Parmar
Overview
Dr. Parmar serves as a Director on the Boards of Akouos (NASDAQ: AKUS), Ensoma, Entrada (NASDAQ: TRDA), GlycoEra, Homology (NASDAQ: FIXX), Rallybio (NASDAQ: RLYB) and Vor Biopharma (NASDAQ: VOR). Prior to 5AM, Dr. Parmar was at Harvard Medical School, where he was an NIH-sponsored M.D./Ph.D. Physician Scientist Fellow in the Harvard-MIT Health Sciences and Technology Program. He completed clinical clerkships at the Massachusetts General & Brigham and Women’s Hospitals. At Princeton University, Dr. Parmar worked on developmental genetics with Eric F. Wieschaus (Nobel Prize in Medicine in 1995).
Reach Kush M Parmar directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Kush M Parmar
What sectors does Kush M Parmar invest in?
Kush M Parmar invests in BioTech, and is based in Boston, Massachusetts. Kush M Parmar is listed as a investor in the ConnectSafely investor database.
What stage does Kush M Parmar invest at?
Kush M Parmar backs companies at Seed and Series A, writing cheques of $0 - $100K.
Which regions does Kush M Parmar invest in?
Kush M Parmar invests across US/Canada.
How do I contact Kush M Parmar?
Kush M Parmar's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database